Longworth, Louise http://orcid.org/0000-0003-2512-4862
Fountain, Donna
Singh, Jeshika
Azzabi, Ismail
Owen, Glynn
Lundstam, Ulf
Sebastian, Shaji
Funding for this research was provided by:
Takeda Oncology
Article History
First Online: 17 December 2018
Compliance with Ethical Standards
:
: This research and preparation of the manuscript was funded by Takeda Pharmaceuticals.
: Ismail Azzabi and Glynn Owen were employees at Takeda when this study was conducted. Shaji Sebastian has received grants and consulting fees from Takeda. Ulf Lundstarm has received consultancy fees from Takeda. Louise Longworth, Donna Fountain and Jeshika Singh declare that they have no conflict of interest.
: Data subject to third-party restriction. The data that support the findings of this study are available from Takeda Pharmaceuticals but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the authors upon reasonable request and with permission of Takeda Pharmaceuticals.